logo

For the Inventor, By the Inventor

Wechelderzande, Belgium

Jean Louis Mesens

This inventor holds 20 USPTO granted patents, plus 1 CIPO patent, primarily in Pharmaceutical Formulations. Top assignees: Janssen Pharmaceutica Nv, Alkermes Controlled Therapeutics, Inc. Ii, Janssen Pharmaceutica. Active years: 1980-2009.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Jean Louis Mesens. Retrieved from https://idiyas.com/inventor/jean-louis-mesens

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 20

% Patents Active = 80.0


Average Co-Inventor Count = 2.6

ph-index = 13

Forward Citations = 695(Granted Patents)


Location History:

  • Geel, BE (1980 - 1981)
  • B-2275-Wechelderzande, BE (1994)
  • Wechelderzande, BE (1990 - 2009)

Company Filing History:

goldMedal9 out of 2,101 
 
Janssen Pharmaceutica Nv
 patents
silverMedal6 out of 36 
 
Alkermes Controlled Therapeutics, Inc. Ii
 patents
bronzeMedal6 out of 32 
 
Janssen Pharmaceutica
 patents
4. 1 out of 77 
 
Alkermes, Inc.
 patents
5. 1 out of 1 
 
Janssen Pharmaceutica N.v. Frame-543
 patent
6. 4 out of 834,513 
Other
 patents
where one patent can have more than one assignee

Years Active: 1980-2009

Loading Chart...
Loading Chart...
Areas of Expertise:
Microencapsulation
Pharmaceutical Compositions
Azole Antifungals
Extended Shelf-Life
Biodegradable
Iontophoretic Delivery
Risperidone Pamoate
Cyclodextrin
Stereoisomers
Antimigraine Drug
Erythropoietin Formulation
20 patents (USPTO):Explore Patents
1. 7547452 - Microencapsulated 3-piperidinyl-substituted 1,2-benzisoxazoles and 1,2-benzisothiazoles (2009-06-16),
2. 7118763 - Microencapsulated 3-piperidinyl-substituted 1,2-benzisoxazoles and 1,2-benzisothiazoles (2006-10-10),
3. 6803055 - Microencapsulated 3-piperidinyl-substituted 1,2-benzisoxazoles and 1,2-benzisothiazoles (2004-10-12),
4. 6544559 - Microencapsulated 3-piperidinyl-substituted 1,2-benzisoxazoles and 1,2-benzisothiazoles (2003-04-08),
5. 6368632 - Microencapsulated 3-piperidinyl-substituted 1,2-benzisoxazoles and 1,2-benzisothiazoles (2002-04-09),
6. 6346518 - Itraconazole and saperconazole stereoisomers (2002-02-12),
7. 6110921 - Microencapsulated 3-piperidinyl-substituted 1,2-benzisoxazoles and (2000-08-29),
8. 5998413 - Itraconazole and stereoisomers (1999-12-07),
9. 5965168 - Microencapsulated 3-piperidinyl-substituted 1,2-benzisoxazoles and (1999-10-12),
10. 5792477 - Preparation of extended shelf-life biodegradable, biocompatible (1998-08-11),
11. 5770231 - Microencapsulated 3-piperidinyl-substituted 1,2-benzisoxazoles (1998-06-23),
12. 5723467 - Method of treating psychotic disorders using risperidone pamoate (1998-03-03),
13. 5707977 - Watersoluble azole antifungals (1998-01-13),
14. 5688801 - Method of inhibiting neurotransmitter activity using microencapsulated (1997-11-18),
15. 5674871 - Iontophoretic delivery of an antimigraine drug (1997-10-07),

Title: Jean Louis Mesens - Innovative Inventor from Wechelderzande

Introduction: Jean Louis Mesens is a talented inventor hailing from Wechelderzande, Belgium, known for his groundbreaking contributions to various fields.

Latest Patents: Jean Louis Mesens has recently been granted patents for his inventions in the fields of renewable energy technologies and sustainable agriculture practices.

Career Highlights: Mesens has had a distinguished career marked by a series of successful inventions that have significantly impacted industries such as healthcare, transportation, and environmental conservation.

Collaborations: Throughout his career, Jean Louis Mesens has collaborated with leading research institutions, universities, and companies to further develop and commercialize his innovative ideas.

Conclusion: Jean Louis Mesens continues to be a driving force in the world of innovation, with his passion for creating solutions that address pressing global challenges setting him apart as a visionary inventor.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…